How A Surgeon Came To Be A Biopharma CEO
Source: Life Science Leader
In this executive virtual roundtable (EVR) segment, Roger Crystal, M.D., president and CEO of Opiant Pharmaceuticals, a biopharma focused on the treatment of addiction and drug overdose, explains how he, a surgeon, came to be the CEO of Opiant 10 years ago, albeit initially part-time.
View the full presentation here.
This website uses cookies to ensure you get the best experience on our website. Learn more